59 related articles for article (PubMed ID: 30648543)
1. The role of Slit2 as a tumor suppressor in thyroid cancer.
Jeon MJ; Lim S; You MH; Park Y; Song DE; Sim S; Kim TY; Shong YK; Kim WB; Kim WG
Mol Cell Endocrinol; 2019 Mar; 483():87-96. PubMed ID: 30648543
[TBL] [Abstract][Full Text] [Related]
2. Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT.
Xia Y; Wang L; Xu Z; Kong R; Wang F; Yin K; Xu J; Li B; He Z; Wang L; Xu H; Zhang D; Yang L; Wu JY; Xu Z
Cell Prolif; 2019 May; 52(3):e12606. PubMed ID: 30896071
[TBL] [Abstract][Full Text] [Related]
3. circVAPA-rich small extracellular vesicles derived from gastric cancer promote neural invasion by inhibiting SLIT2 expression in neuronal cells.
Xia Y; Jiang T; Li Y; Gu C; Lv J; Lu C; Xu P; Fang L; Chen Z; Liu H; Zhang D; Xu H; Yang L; Xu Z; Wang L
Cancer Lett; 2024 Jun; 592():216926. PubMed ID: 38714291
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of medulloblastoma cell invasion by Slit.
Werbowetski-Ogilvie TE; Seyed Sadr M; Jabado N; Angers-Loustau A; Agar NY; Wu J; Bjerkvig R; Antel JP; Faury D; Rao Y; Del Maestro RF
Oncogene; 2006 Aug; 25(37):5103-12. PubMed ID: 16636676
[TBL] [Abstract][Full Text] [Related]
5. Thyroid Cancer: Focus on Invasion and Metastasis Mechanisms, Therapeutic Target and Drug Treatment.
Vasko V
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835455
[TBL] [Abstract][Full Text] [Related]
6. Targeting the SLIT/ROBO pathway in tumor progression: molecular mechanisms and therapeutic perspectives.
Jiang Z; Liang G; Xiao Y; Qin T; Chen X; Wu E; Ma Q; Wang Z
Ther Adv Med Oncol; 2019; 11():1758835919855238. PubMed ID: 31217826
[TBL] [Abstract][Full Text] [Related]
7. Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis.
Tavora B; Mederer T; Wessel KJ; Ruffing S; Sadjadi M; Missmahl M; Ostendorf BN; Liu X; Kim JY; Olsen O; Welm AL; Goodarzi H; Tavazoie SF
Nature; 2020 Oct; 586(7828):299-304. PubMed ID: 32999457
[TBL] [Abstract][Full Text] [Related]
8. The Role of the Slit/Robo Signaling Pathway.
Tong M; Jun T; Nie Y; Hao J; Fan D
J Cancer; 2019; 10(12):2694-2705. PubMed ID: 31258778
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy.
Lin Q; Li S; Jiang N; Jin H; Shao X; Zhu X; Wu J; Zhang M; Zhang Z; Shen J; Zhou W; Gu L; Lu R; Ni Z
Autophagy; 2021 Oct; 17(10):2975-2990. PubMed ID: 33345685
[TBL] [Abstract][Full Text] [Related]
10. RNF186 regulates EFNB1 (ephrin B1)-EPHB2-induced autophagy in the colonic epithelial cells for the maintenance of intestinal homeostasis.
Zhang H; Cui Z; Cheng D; Du Y; Guo X; Gao R; Chen J; Sun W; He R; Ma X; Peng Q; Martin BN; Yan W; Rong Y; Wang C
Autophagy; 2021 Oct; 17(10):3030-3047. PubMed ID: 33280498
[TBL] [Abstract][Full Text] [Related]
11. The potential of Slit2 as a therapeutic target for central nervous system disorders.
Sherchan P; Travis ZD; Tang J; Zhang JH
Expert Opin Ther Targets; 2020 Aug; 24(8):805-818. PubMed ID: 32378435
[No Abstract] [Full Text] [Related]
12. Regulatory mechanisms of Robo4 and their effects on angiogenesis.
Dai C; Gong Q; Cheng Y; Su G
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31160487
[TBL] [Abstract][Full Text] [Related]
13. Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages.
Ahirwar DK; Charan M; Mishra S; Verma AK; Shilo K; Ramaswamy B; Ganju RK
Cancer Res; 2021 Oct; 81(20):5255-5267. PubMed ID: 34400395
[TBL] [Abstract][Full Text] [Related]
14. Cancer associated fibroblast derived SLIT2 drives gastric cancer cell metastasis by activating NEK9.
Lu G; Du R; Dong J; Sun Y; Zhou F; Feng F; Feng B; Han Y; Shang Y
Cell Death Dis; 2023 Jul; 14(7):421. PubMed ID: 37443302
[TBL] [Abstract][Full Text] [Related]
15. HIF-1 Interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia.
Yang Y; Lu H; Chen C; Lyu Y; Cole RN; Semenza GL
Nat Commun; 2022 Jan; 13(1):316. PubMed ID: 35031618
[TBL] [Abstract][Full Text] [Related]
16. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
17. Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway.
Li P; Lin Z; Liu Q; Chen S; Gao X; Guo W; Gong F; Wei J; Lin H
Front Oncol; 2021; 11():743840. PubMed ID: 34722297
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
19. Clinical and therapeutic relevance of cancer-associated fibroblasts.
Chen Y; McAndrews KM; Kalluri R
Nat Rev Clin Oncol; 2021 Dec; 18(12):792-804. PubMed ID: 34489603
[TBL] [Abstract][Full Text] [Related]
20. RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment.
Park HH; Kim HR; Park SY; Hwang SM; Hong SM; Park S; Kang HC; Morgan MJ; Cha JH; Lee D; Roe JS; Kim YS
Mol Cancer; 2021 Aug; 20(1):107. PubMed ID: 34419074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
